sepsi
remain
major
caus
mortal
intens
care
past
year
seen
uniform
worldwid
approach
manag
sepsi
sever
sepsi
septic
shock
improv
surviv
recogn
earli
symptom
sign
sepsi
key
confus
hypox
hypotens
patient
pyrexia
tachycardia
tachypnoea
leucocytosi
examin
must
includ
search
sourc
infect
earli
drainag
debrid
next
take
appropri
cultur
give
fluid
broadspectrum
antibiot
pictur
improv
next
hour
stepup
treatment
includ
urin
output
monitor
blood
gase
base
excess
lactat
haemoglobin
glucos
guid
manag
vasopressor
insulin
fluid
transfus
bicarbon
hypotens
persist
septic
shock
patient
move
intens
care
recent
recommend
includ
withdraw
starch
base
colloid
dobutamin
place
dopamin
higher
threshold
use
steroid
institut
within
hour
start
sepsi
advanc
care
includ
mechan
ventil
use
ardsnet
protocol
prevent
screen
stop
cross
infect
appropri
use
antibiot
remain
first
prioriti
sepsi
cover
wide
rang
condit
usual
requir
admiss
intens
care
unit
icu
unless
becom
sever
occur
patient
often
need
icu
broadli
account
admiss
accord
patient
popul
impact
type
septic
problem
communityacquir
infect
versu
nosocomi
hospitalacquir
infect
medic
icu
far
communityacquir
infect
icu
admit
elect
surgic
patient
whatev
sourc
infect
lead
sepsi
remain
major
intens
care
problem
mortal
least
sever
sepsi
sepsi
induc
signific
organ
dysfunct
tissu
hypoperfus
box
septic
shock
induc
hypotens
persist
despit
adequ
fluid
resuscit
system
inflammatori
respons
syndrom
sir
syndrom
two
gener
variabl
shown
box
mean
patient
septic
thu
sepsi
defin
sir
evid
infect
sepsi
respons
diseas
defin
level
respons
manag
level
manifest
provid
opportun
start
treatment
earli
influenc
outcom
normal
immun
physiolog
respons
erad
pathogen
sepsi
imbal
normal
regul
may
caus
continu
activ
pathogen
high
level
circul
antiinflammatori
cytokin
impair
immun
function
see
rapid
lymphocyt
apoptosi
delay
apoptosi
neutrophil
enhanc
necrosi
cell
coagul
system
also
affect
increas
coagul
diminish
fibrinolyt
activ
conjunct
excess
inflammatori
respons
loss
homoeostat
balanc
among
system
result
gener
coagulopathi
microvascular
thrombosi
lead
acut
organ
failur
death
variou
treatment
aim
modifi
respons
use
biomark
direct
treatment
predict
outcom
system
manifest
associ
sepsi
gener
variabl
c
core
temperatur
c
c
c
heart
rate
bpm
c
tachypnoea
may
feel
respiratori
distress
rate
pm
c
signific
oedema
posit
fluid
balanc
mlkg
hour
c
hyperglycaemiaplasma
glucos
mmol
l
diabet
higher
risk
inflammatori
variabl
c
leucocytosi
wbc
count
ml
c
leukopenia
wbc
count
ml
c
plasma
creactiv
protein
sd
normal
valu
c
plasma
procalcitonin
sd
normal
valu
routin
hospit
translat
guidelin
clinic
practic
establish
worldwid
databas
would
enabl
campaign
achiev
aim
reduct
mortal
maintain
databas
refin
treatment
publish
result
complianc
phase
iv
result
databas
centr
worldwid
publish
show
signific
improv
surviv
protocol
compliant
though
well
known
amongst
intensivist
campaign
less
well
known
doctor
work
wide
hospit
patient
come
ward
via
accid
emerg
emphasi
first
hour
care
import
doctor
awar
best
current
guidelin
treat
sepsi
particular
time
zero
protocol
start
admiss
accid
emerg
depart
patient
arriv
icu
manag
seem
prescript
care
bundl
use
inevit
drive
global
standard
make
treatment
protocol
easi
use
rememb
audit
recogn
septic
patient
easi
diagnosi
consid
howev
longer
patient
remain
untreat
receiv
inadequ
treatment
wors
prognosi
patient
may
anoth
underli
condit
arthriti
diabet
ischaem
heart
diseas
etc
caus
feel
unwel
ask
fever
chill
lethargi
confus
weak
bowel
habit
appetit
headach
etc
doctor
need
cover
system
exampl
lung
infect
caus
short
breath
purul
sputum
urinari
tract
infect
may
caus
dysuria
pungent
smell
urin
abdomin
infect
caus
pain
look
whole
patient
figur
pyrexia
tachycardia
tachypnoea
pain
swell
stage
identifi
site
specif
infect
crucial
choic
antibiot
obtain
cultur
diagnost
criteria
suspect
sepsi
defin
whether
patient
sepsi
uncompl
sever
determin
treatment
plan
patient
septic
without
criteria
sever
sepsi
cultur
taken
blood
screen
site
specif
antibiot
fluid
supplement
oxygen
accord
sao
valu
patient
sever
sepsi
move
advanc
paradigm
patient
suspect
sever
sepsi
manag
least
higher
depend
area
access
central
venou
pressur
monitor
supplement
oxygen
therapi
diagnost
full
screen
swab
must
includ
urin
sputum
drain
pu
appar
sourc
also
blood
cultur
vascular
line
direct
peripher
vein
success
isol
pathogen
like
cultur
taken
prior
antibiot
therapi
antibiot
antibiot
prescrib
accord
hospit
protocol
principl
start
broadspectrum
antibiot
earli
continu
day
cultur
evid
sourc
time
deescal
narrow
spectrum
begin
overal
therapi
day
unless
determin
infect
sourc
ill
sign
organ
dysfunct
associ
sever
sepsi
c
sepsisinduc
hypotens
c
lactat
greater
mmol
l
c
urin
output
mlkghr
hour
despit
fluid
resuscit
c
ali
pao
fio
absenc
pneumonia
infect
sourc
c
ali
pao
fio
presenc
pneumonia
infect
sourc
sourc
control
collect
drain
debrid
invas
devic
cathet
remov
chang
may
need
repeat
ill
fluid
therapi
goal
fluid
therapi
increas
circul
volum
ensur
vasoconstrictor
go
use
patient
adequ
fill
thu
central
venou
pressur
cvp
mmhg
spontan
breath
mmhg
ventil
patient
target
fluid
challeng
use
requir
clinic
awar
patient
condit
initi
fluid
challeng
patient
sepsisinduc
tissu
hypoperfus
hypovolaemia
mlkg
crystalloid
minut
greater
amount
consid
albumin
target
mlkg
crystalloid
colloid
observ
blood
pressur
central
venou
pressur
respons
determin
treatment
continu
albumin
show
advantag
compar
crystalloid
studi
patient
metaanalysi
dextran
starch
gelatin
versu
crystalloid
show
mortal
differ
howev
chest
studi
show
increas
renal
dysfunct
use
starch
caution
requir
cardiac
failur
possibl
echocardiograph
assess
recommend
differ
sever
sepsi
septic
shock
respons
time
patient
fit
criteria
sever
sepsi
adequ
fluid
therapi
maximum
hour
remain
hypotens
hypoperfus
lactat
mmol
l
consid
septic
shock
manag
accordingli
may
proceed
quicker
hour
time
frame
import
point
patient
left
inadequ
perfus
pressur
long
period
stage
manag
requir
intens
care
box
although
guidelin
recommend
cvp
monitor
central
venou
satur
scvo
achiev
therapeut
goal
recent
data
may
chang
process
trail
show
differ
use
earli
invas
monitor
similar
result
came
australasian
resuscit
sepsi
evalu
aris
trial
present
yet
publish
european
societi
intens
care
medicin
meet
barcelona
harm
shown
surviv
sepsi
campaign
protocol
remain
review
nevertheless
mix
venou
oxygen
satur
svo
tip
pulmonari
arteri
cathet
pac
cvp
give
inform
oxygen
suppli
demand
surrog
marker
adequaci
cardiac
gener
cardiac
index
l
min
consid
adequ
howev
individu
may
high
low
pac
also
give
inform
system
vascular
resist
guid
vasopressor
therapi
howev
data
show
improv
outcom
pac
use
declin
use
scvo
guid
lower
valu
prompt
increas
oxygen
transport
either
increas
cardiac
output
increas
oxygen
carri
capac
ie
correct
anaemia
higher
valu
reassur
allow
reduct
inotrop
avoid
transfus
measur
precis
oxygen
deliveri
target
supranorm
valu
longer
common
practic
surrog
cardiac
output
lactat
base
excess
urin
output
doubt
see
base
excess
correct
good
sign
lack
specif
neg
base
excess
correct
bicarbon
sole
aim
correct
indic
tissu
perfus
clinician
feel
myocardi
perform
compromis
consid
case
studi
ventil
patient
start
base
excess
ph
deterior
next
hour
base
excess
gradual
increas
ph
despit
escal
inotrop
point
patient
receiv
ml
bicarbon
appear
adequ
fluid
resuscit
inotrop
stabil
function
fill
echo
guid
caus
immedi
chang
base
excess
ph
buffer
given
subsequ
hour
base
excess
return
ph
base
excess
provid
use
inform
tissu
perfus
shortli
patient
extub
ph
acut
set
heart
affect
urin
output
good
sign
renal
perfus
therefor
cardiac
output
howev
respons
slow
affect
factor
echocardiographi
best
bedsid
tool
monitor
cardiac
function
fill
ultrasound
platform
multimod
machin
use
vascular
access
chest
ultrasound
use
cardiac
ultrasound
need
correct
probe
echocardiograph
assess
left
ventricl
lv
led
increas
awar
impact
sepsi
lv
function
common
see
young
patient
would
eject
fraction
ef
ef
postev
cardiac
function
recov
ischaem
valvular
heart
diseas
baron
show
patient
ventil
septic
shock
show
impair
lv
function
partial
correct
dobutamin
function
recoveri
affect
surviv
echo
also
show
right
ventricular
dysfunct
carri
much
wors
prognosi
influenc
cvp
read
simpl
measur
lv
dimens
guid
fill
requir
measur
inferior
vena
cava
ivc
respons
fluid
challeng
respiratori
variat
add
inform
fill
patient
inform
obtain
transthorac
echo
although
variou
studi
inotrop
vasopressor
use
littl
real
scienc
separ
noradrenalin
drug
common
use
nurs
staff
familiar
known
excess
use
vasoconstrictor
caus
splanchnic
renal
hypoperfus
howev
noradrenalin
favour
profil
event
sepsi
adequ
fill
pressur
vasopressin
appear
second
choic
shown
plasma
level
low
septic
patient
adrenalin
first
choic
inotrop
dobutamin
second
tend
replac
dopamin
adrenalin
consid
alongsid
noradrenalin
use
outsid
intens
care
central
venou
access
avail
less
potent
inotrop
support
requir
icu
dopamin
rel
good
cardiac
safeti
profil
despit
concern
effect
hormon
clinic
signific
unknown
use
steroid
septic
shock
vari
year
howev
support
cochran
review
use
manag
requir
intens
care
steroid
hypotens
persist
despit
fluid
pressor
therapi
commonli
hydrocortison
mg
hour
day
howev
european
studi
confirm
benefici
effect
revers
shock
fail
show
mortal
benefit
use
lowdos
steroid
hydrocortison
prefer
dexamethason
due
mineralocorticoid
effect
sepsi
campaign
recommend
restrict
use
steroid
transfus
polici
vari
trial
septic
patient
thu
optim
haemoglobin
known
river
studi
target
haematocrit
hct
use
studi
haemoglobin
rang
gdl
compar
higher
haemoglobin
shown
detriment
lower
valu
thu
target
gdl
hct
recommend
although
higher
valu
may
desir
specif
patient
group
use
fresh
frozen
plasma
platelet
bleed
patient
surgic
intervent
plan
case
platelet
given
count
current
guidelin
recommend
use
cryoprecipit
measur
valu
fibrinogen
degrad
product
howev
fresh
plasma
cryoprecipit
use
face
coagulopathi
past
year
move
toward
protect
lung
ventil
strategi
mani
septic
patient
requir
mechan
ventil
noninvas
ventil
desir
less
effect
sepsi
compar
respiratori
diseas
half
patient
acut
lung
injuri
caus
effect
septicaemia
time
vulner
barotrauma
caus
ventilationmod
use
oper
room
turn
result
acut
respiratori
distress
syndrom
ard
carri
high
mortal
morbid
especi
patient
year
age
basic
principl
use
low
tidal
volum
mlkg
keep
inspir
plateau
pressur
cm
h
recruit
strategi
allow
permiss
hypercapnia
call
ardsnet
strategi
though
precis
valu
paco
establish
consid
reason
allow
respiratori
acidosi
around
ph
van
den
bergh
present
work
tight
blood
glucos
control
european
societi
intens
care
medicin
show
reduct
sepsi
relat
mortal
postop
intens
care
popul
follow
nearli
intens
care
patient
receiv
addit
artifici
calori
intens
insulin
therapi
seem
intuit
correct
run
high
blood
glucos
bad
thing
presenc
bacteraemia
howev
subsequ
studi
show
far
less
dramat
find
mani
found
hypoglycaemia
problem
nicesugar
studi
patient
compar
tight
glucos
control
normal
valu
glucos
kept
mmoll
found
increas
mortal
episod
hypoglycaemia
tight
group
nutrit
feed
septic
patient
remain
controversi
sourc
sepsi
variabl
difficult
compar
like
like
survey
icu
german
hospit
specif
look
feed
septic
patient
found
patient
fed
parenter
mix
parenteralenter
nutrit
greater
mortal
compar
enter
alon
howev
multicentr
italian
studi
show
excess
mortal
septic
patient
receiv
enter
immunenutrit
compar
parenter
nutrit
studi
stop
current
posit
recommend
specif
immunenutrit
consid
section
cardiac
assess
best
approach
sepsi
prevent
first
place
role
everyon
involv
patient
stop
infect
start
prevent
spread
thought
need
given
like
pathogen
make
effect
design
organ
unit
crucial
role
side
room
optim
patient
long
staf
allow
proper
care
design
also
consid
wash
facil
everyon
abl
handwash
effect
accept
methicillinresist
staphylococcu
aureu
mrsa
must
screen
screen
effect
reduc
incid
mrsa
infect
mrsa
screen
becom
less
preval
pathogen
increas
note
icu
multiresist
gram
neg
organ
mainli
acinetobact
spp
extend
spectrumelactamas
produc
gram
neg
esbl
stenotrophomona
maltophilia
gentamicinresist
pseudomona
aeruginosa
esbl
enzym
found
mani
pathogen
klebsiella
pneumonia
escherichia
coli
salmonella
pseudomona
pathogen
widespread
import
decis
treatment
start
distinguish
colon
infect
choic
antibiot
need
involv
microbiolog
infect
control
team
treatment
often
need
prolong
week
involv
isol
inde
antibiot
treatment
key
infect
prevent
across
hospit
ideal
done
infect
control
team
accord
strict
hospit
guidelin
clostridium
difficil
signific
problem
icu
report
case
uk
sinc
increas
case
occur
patient
year
adult
carrier
percentag
much
higher
babi
patient
acquir
infect
hospit
ingest
spore
spore
surviv
gastric
acid
prolifer
antibiot
reduc
flora
larg
intestin
toxin
produc
caus
coliti
rang
mild
diarrhoea
pseudomembran
coliti
vulner
patient
lethal
condit
alway
lead
prolong
isol
icu
hand
hygien
clean
isol
care
control
antibiot
prescrib
limit
spread
preval
invas
cathet
central
line
alway
insert
semisteril
way
becom
sourc
bacteraemia
patient
awar
problem
improv
gener
approach
line
insert
achiev
variou
bodi
recent
match
michigan
work
done
michigan
show
sepsi
line
problem
institut
packag
care
bundl
cover
aspect
line
insert
problem
could
reduc
extracorpor
membran
oxygen
ecmo
previous
sepsi
contraind
ecmo
chang
sick
also
viral
diseas
seen
coronaviru
though
strictli
sepsi
creat
lot
interest
use
ecmo
bring
high
mortal
associ
treatment
option
remain
special
centr
number
centr
increas
surviv
sepsi
campaign
increas
awar
made
avail
packag
care
practic
achiev
care
bundl
sepsi
resuscit
bundl
shown
box
detract
manag
patient
individu
valu
aid
memoir
provid
format
accur
audit
articl
includ
addit
relev
aspect
care
advanc
deserv
wider
accept
icu
uk
uk
sepsi
group
call
sepsi
govern
prioriti
nation
registri
howev
clinic
manag
clear
individu
intens
care
doctor
deliv
standard
care
recognit
cultur
debrid
treatment
advanc
treatment
none
respond
within
hour
